Text Version
Entrez PubMed Overview Help | FAQ Tutorial New/Noteworthy E-Utilities
PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher Clinical Queries LinkOut Cubby
Related Resources Order Documents NLM
Gateway TOXNET Consumer
Health Clinical Alerts ClinicalTrials.gov PubMed
Central
Privacy Policy
|
|
-
Bupropion (Zyban)
toxicity.
Tracey JA, Cassidy N, Casey PB, Ali
I.
The National Poisons Information Centre, Beaumont
Hospital, Dublin, Ireland.
Bupropion is a monocyclic
antidepressant structurally related to amphetamine. Zyban, a
sustained-release formulation of bupropion hydrochloride, was recently
released in Ireland, as a smoking cessation aid. In the initial 6 months
since it's introduction, 12 overdose cases have been reported to The
National Poisons Information Centre. 8 patients developed symptoms of
toxicity. Common features included tachycardia, drowsiness,
hallucinations and convulsions. Two patients developed severe cardiac
arrhythmias, including one patient who was resuscitated following a
cardiac arrest. All patients recovered without sequelae. We report a
case of a 31 year old female who required admission to the Intensive
Care Unit for ventilation and full supportive therapy, following
ingestion of 13.5g bupropion. Recurrent seizures were treated with
diazepam and broad complex tachycardia was successfully treated with
adenosine. Zyban caused significant neurological and cardiovascular
toxicity in overdose. The potential toxic effects should be considered
when prescribing it as a smoking cessation aid.
Publication
Types:
PMID: 11928786 [PubMed - indexed for
MEDLINE]
|